Evaluation studies show new insights concerning Ras/MAPK hyperactivation as a shared pathway, promising endocrine and homeostatic approaches, such as energy homeostasis (e.g. by leptin and insulin), calcium homeostasis and future treatments from the field of RAS-driven cancers. The gene discussed is INS; the disease is cancer.